Bayer announced that the European Commission has granted approval in the European Union (EU) for Kerendia (finerenone), a selective, non-steroidal mineralocorticoid receptor antagonist (nsMRA), for the treatment of… read more.
In a new study published in Clinical Gastroenterology and Hepatology, the low FODMAP diet and the antibiotic rifaximin provided similar and significant relief for patients with irritable bowel syndrome with diarrhea (IBS-D). Researchers also observed distinct… read more.
Delaying hepatitis B vaccination after birth increases infections among newborns and decreases their survival rates and quality of life, according to a new Cornell University study. The paper,… read more.
H. Lundbeck A/S y presented new real-world 6-month results from the INFUSE study at the American Academy of Neurology (AAN) 2026 Annual Meeting, underscoring the importance of evaluating… read more.
Younger children and teens often have built-in opportunities to stay active through gym class, sports and extracurricular activities. But after high school, those structured options often disappear. And… read more.
A healthy diet, weight loss, and increased physical activity can effectively prevent type 2 diabetes. However, not all individuals at elevated diabetes risk benefit equally from lifestyle interventions…. read more.
The European Commission has granted a conditional marketing authorisation for Rezurock (belumosudil) for the treatment of chronic graft-versus-host disease (GVHD) in adults and in children aged 12 years… read more.
UPMC and University of Pittsburgh clinician-scientists have weaned and kept multiple liver transplantation patients off of all immunosuppressant drugs for more than three years through a first-in-human clinical trial of a… read more.
The use of psilocybin, the hallucinogenic compound found in “magic mushrooms,” is rising in the United States alongside de‑criminalization efforts in several states and local jurisdictions, as well… read more.
Novartis announced that the World Health Organization (WHO) has prequalified Coartem® (artemether-lumefantrine) Baby, the first and only antimalarial developed specifically for newborns and young infants weighing from 2… read more.
In the new study, published today in the International Journal of Behavioural Nutrition and Physical Activity, researchers tested the change in six English worksite cafeterias, asking managers to swap… read more.
In an increasingly digital world, millions of disabled people are being systematically excluded from critical services every day, from their medical records to bank accounts to emergency response… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
